Document is current
Any future updates will be listed below
-
Authors
Linscott, Joshua A.
Miyagi, Hiroko
Murthy, Prithvi B.
Yao, Sijie
Grass, G. Daniel
Vosoughi, Aram
Xu, Hongzhi
Wang, Xuefeng
Yu, Xiaoqing
Yu, Alice
Zemp, Logan
Gilbert, Scott M.
Poch, Michael A.
Sexton, Wade J.
Spiess, Philippe E.
Li, Roger
- License Information
-
More Information
Article History
Accepted: 20 May 2024
First Online: 5 June 2024
Declarations
:
: The authors did not receive support from any organization for the submitted work. Financial conflicts of interest: Joshua Linscott, Hiroko Miyagi, Prithvi Murthy, Sijie Yao, G. Daniel Grass, Aram Vosoughi, Hongzhi Xu, Xuefeng Wang, Xiaoqing Yu, Alice Yu, Logan Zemp, Scott M. Gilbert, Michael A. Poch, Wade J. Sexton, declare no conflict of interest; Philippe E. Spiess has no financial disclosures; only leadership role disclosure (nonfinancially compensated as NCCN Bladder and Penile Cancer Vice-chair); Roger Li has received research support from Predicine, Veracyte, CG Oncology, Valar labs, Merck, and Janssen, serves as a consultant for BMS, Merck, Thericon, CG Oncology, and has honoraria from SAI MedPartners, Solstice Health Communications, Putnam Associates, UroToday, MJH Lifesciences
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Joshua Linscott, Hiroko Miyagi, Prithvi Murthy, Sijie Yao, G. Daniel Grass, Aram Vosoughi, Hongzhi Xu, Xuefeng Wang, Xiaoqing Yu, Alice Yu, Logan Zemp, Scott M. Gilbert, Michael A. Poch, Wade J. Sexton, declare no conflict of interest; Philippe E. Spiess has no financial disclosures; only leadership role disclosure (nonfinancially compensated as NCCN Bladder and Penile Cancer Vice-chair); Roger Li has received research support from Predicine, Veracyte, CG Oncology, Valar labs, Merck, and Janssen, serves as a consultant for BMS, Merck, Thericon, CG Oncology, and has honoraria from SAI MedPartners, Solstice Health Communications, Putnam Associates, UroToday, MJH Lifesciences.
